Clinical Trial Update: Finerenone Plus SGLT2 Inhibitors in Heart Failure [Phase 4]

View source ↗

Summary

This Clinical Trial Update notes a Phase 4 study assessing finerenone in combination with SGLT2 inhibitors for heart failure, with recruitment not yet started.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Finerenone (finerenone)
• SGLT2 inhibitors (SGLT2 inhibitor)

Snippet

Sponsor: Mansoura University | Conditions: Heart Failure | Phase 4 | Status: NOT_YET_RECRUITING